Relaya vs mFine
vs
mFine burned through $100M+ in VC funding and shut down in 2023. Clinics that depended on them woke up one morning with no platform. Here's why that happened and how to avoid it.
Note: mFine ceased operations in 2023 after running out of funding. Their teleconsultation marketplace model proved unsustainable. Clinics that relied on mFine for patient acquisition were left without a platform overnight.
| Feature | Relaya | mFine (defunct) |
|---|---|---|
| Currently Operational | ||
| AI Voice Agent | ||
| Clinical AI Scribe | ||
| WhatsApp Integration | ||
| Practice Management | ||
| Patient Data Ownership | ||
| Online Consultations | ||
| Multi-specialty | ||
| India Market Focus | ||
| Sustainable Business Model | ||
| Independent Clinic Focus | ||
| No Marketplace Dependency |
What mFine's shutdown teaches us
Never let a platform own your patient relationships. mFine controlled the connection between doctor and patient. Platform dies? Connection dies. Overnight, clinics lost access to the patients they'd been seeing for months. On Relaya, your patient data is yours. Export it anytime. No lock-in.
Marketplace models are fragile by design. mFine subsidized patient consultations with VC money. When funding dried up, the economics collapsed. That's not a business model, it's a timer. Relaya charges clinics a flat monthly fee for software they find valuable. Simple economics that don't depend on infinite fundraising.
SaaS that grows because it works, not because it's cheap. mFine grew by offering artificially cheap consultations. Remove the subsidy, remove the users. Relaya grows because clinics operate measurably better with AI scheduling, voice agents, and auto-documentation. The value is in the tooling, not the discount.
AI should augment doctors, not replace them. mFine tried AI triage. replacing the doctor as much as possible. That's the wrong bet. Relaya uses AI for the admin work: answering phones, writing notes, chasing follow-ups. The doctor does the medicine. The AI does the paperwork.
Choose software that survives because it's useful, not because it's funded
Flat pricing. Real value. Your patients stay yours even if we disappear tomorrow (we won't, but the data is always exportable).
Book a demo